AuroraMed v0.2.0 is a synthetic-data pilot. See exactly what's built →

Security, privacy and audit requirements · C0919

Are substance-use, psychotherapy and reproductive-health records handled separately?

Designed, not yet built

Short answer

How would it be tested? The specification says part 2 record not disclosed without matching consent; redisclosure notice attached. That is the check for REQ-4404: consent for 42 CFR Part 2 records, psychotherapy notes and reproductive-health-sensitive data must be separate, purpose-specific and revocable. This is on the design side of the line. Nothing in v0.2.0 does it.

This is designed, not built.

Specification item
REQ-4404
Specification priority
P0 (of P0 to P3)
Tiers
Small, Medium, Large

Status as of September 30, 2026. Version 0.2.0, synthetic data only. See what's built today. Not legal, medical or security advice.

Related answers

See it in context: Consent management · Search the help center · Ask a question

See the synthetic-data demo first.Request a demo